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Purpose: To compare the cellular uptake efficiency and cytotoxicity of aminosilane 
(SiO2-NH2)-coated superparamagnetic iron oxide (SPIO@SiO2-NH2) nanoparticles with three 
other types of SPIO nanoparticles coated with SiO2 (SPIO@SiO2), dextran (SPIO@dextran), 
or bare SPIO in mammalian cell lines.
Materials and methods: Four types of monodispersed SPIO nanoparticles with a SPIO 
core size of 7 nm and an overall size in a range of 7–15 nm were synthesized. The mammalian 
cell lines of MCF-7, MDA-MB-231, HT-29, RAW264.7, L929, HepG2, PC-3, U-87 MG, and 
mouse mesenchymal stem cells (MSCs) were incubated with four types of SPIO nanoparticles 
for 24 hours in the serum-free culture medium Dulbecco’s modified Eagle’s medium (DMEM) 
with 4.5 µg/mL iron concentration. The cellular uptake efficiencies of SPIO nanoparticles were 
compared by Prussian blue staining and intracellular iron quantification. In vitro magnetic 
resonance imaging of MSC pellets after SPIO labeling was performed at 3 T. The effect of 
each SPIO nanoparticle on the cell viability of RAW 264.7 (mouse monocyte/macrophage) 
cells was also evaluated.
Results: Transmission electron microscopy demonstrated surface coating with SiO2-NH2, SiO2, 
and dextran prevented SPIO nanoparticle aggregation in DMEM culture medium. MCF-7, 
MDA-MB-231, and HT-29 cells failed to show notable iron uptake. For all the remaining six 
cell lines, Prussian blue staining and intracellular iron quantification demonstrated that SPIO@
SiO2-NH2 nanoparticles had the highest cellular uptake efficiency. SPIO@SiO2-NH2, bare 
SPIO, and SPIO@dextran nanoparticles did not affect RAW 264.7 cell viability up to 200 µg 
Fe/mL, while SPIO@SiO2 reduced RAW 264.7 cell viability from 10 to 200 µg Fe/mL in a 
dose-dependent manner.
Conclusion: Cellular uptake efficiency of SPIO nanoparticles depends on both the cell type 
and SPIO surface characteristics. Aminosilane surface coating enhanced the cellular uptake 
efficiency without inducing cytotoxicity in a number of cell lines.
Keywords: magnetic nanoparticles, SPIO, iron oxide, surface coating, cellular uptake
Introduction
The use of nanoparticles for cellular imaging and drug-targeted delivery is likely to be 
one of most important clinical applications of nanotechnology. Therapeutic and diag-
nostic agents can be encapsulated, covalently attached, or adsorbed onto   nanoparticles. 
In the mesoscopic size range of 5–100 nm diameter, nanoparticles possess large surface 
areas for conjugating to multiple diagnostic and therapeutic agents. Multi-pore nano-
shells are also used for encapsulating drugs. When administrated in vivo, nanoparticles 
can accumulate preferentially at tumor sites through enhanced permeability and reten-
tion effect,1–3 as tumor-associated neovasculatures are highly permeable, allowing the 
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leakage of circulating nanoparticles into the tumor inter-
stitium, and also many tumors lack an effective lymphatic 
drainage, leading to subsequent nanoparticle accumulation. 
Drug resistance is also emerging as a major obstacle limiting 
the therapeutic efficacy of chemotherapeutic agents. Among 
several mechanisms of drug resistance, P-glycoprotein is the 
best known, whereas drugs associated with nanoparticles may 
avoid recognition by the P-glycoprotein efflux pump, leading 
to higher intracellular drug concentrations.4 As an example 
of one clinical application of nanotechnology, in a new for-
mulation approach used in Abraxane® (Celgene   Corporation, 
  Summit, NJ), paclitaxel was conjugated to albumin nanopar-
ticles to treat metastatic breast cancer.5
Superparamagnetic iron oxide (SPIO) nanoparticles are 
one of the most studied biomaterials. To date, dextran-coated 
SPIO nanoparticles, namely ferumoxides (Feridex® [Amag 
Pharmaceuticals, Inc, Cambridge, MA]/Endorem® [Guerbet, 
Paris, France]) and ferucarbotran (Resovist®, Schering AG, 
Berlin, Germany) are clinically approved for liver magnetic 
resonance imaging (MRI). In addition, carboxydextran-
coated SPIO nanoparticles of ferumoxtran (Sinerem®, 
Guerbet) have undergone clinical trials for MRI evaluation 
of lymph node metastasis.6–8 SPIO nanoparticles have further 
important potential for in vivo stem cell tracking,9,10 magnetic 
separation,11 hyperthermia therapy,12 and anticancer drug 
delivery.13–16 For many of these applications, optimized cel-
lular uptake of SPIO nanoparticles by target cells is a critical 
step. One strategy to modulate the cellular uptake efficiency 
or specificity of SPIO nanoparticles is to modify their surface 
coating. In addition to dextran and carboxydextran, a number 
of surface coatings for SPIO nanoparticles, including poly-
ethylene glycol (PEG), polyvinyl alcohol (PVA), dendrimers, 
starch, and silica, have been reported.7,14,17 Among these coat-
ing materials, silica is regarded as a biocompatible material.18 
Bioglass, which contains silica (ca 60 mol%), calcium, and 
phosphorus, has many applications in wound healing, both 
in bone (hard) and soft tissues, middle ear implants, and in 
dentistry.19 Silica coating has the advantages of preventing 
the aggregation of particles in liquid and improvement of 
their chemical stability.20 Moreover, the silica coating of 
nanoparticles can be terminated by a variety of functional 
groups which can be covalently attached to specific ligands 
by various coupling agents.21
Organosilanes such as tetraethyl orthosilicate (TEOS),22–24 
aminopropyltriethoxysilane (APTES),25 or (3-aminopropyl)
trimethoxysilane (APTMS)26 are commonly used to produce 
functionalized thin films of silica coatings on nanoparticles in 
a variety of applications. Among them, APTES is one of the 
most frequently used to produce the aminosilane (SiO2-NH2) 
coating to enhance protein and cell adhesion.27,28 SiO2-NH2-
coated SPIO (SPIO@SiO2-NH2) nanoparticles prepared by 
alkaline hydrolysis of APTES have been reported by the 
present authors29 and other groups.30–32 In a previous study, 
SPIO@SiO2-NH2 nanoparticles were applied to rabbit mesen-
chymal stem cell (MSC) labeling.29 It was shown that SPIO@
SiO2-NH2 nanoparticles had a higher labeling efficiency than 
SiO2-coated SPIO (SPIO@SiO2) nanoparticles. However, 
whether SPIO@SiO2-NH2 nanoparticles offer a universally 
higher internalization efficiency than other surface coatings 
in different mammalian cell lines remains unknown. In this 
present study, the authors attempted to evaluate and compare 
the intracellular uptake of SPIO@SiO2-NH2 with three other 
nanoparticles, namely SPIO@SiO2, bare SPIO, and dextran-
coated SPIO (SPIO@dextran) nanoparticles, in a variety of 
common mammalian cell lines.
Material and methods
Synthesis and characterization  
of SPIO nanoparticles
Ferric chloride hexahydrate (FeCl3  6H2O), ferrous sulfate 
heptahydrate (FeSO4  7H2O), sodium hydroxide,   anhydrous 
absolute ethanol, ammonia solution (20%), APTES, 
tetraethyl orthosilicate (TEOS), and dextran (70 kDa) 
were purchased from Sigma-Aldrich (St Louis, MO) or 
Acros Organics (Pittsburg, PA). For SPIO nanoparticle 
synthesis, the iron oxide core was synthesized by alkaline 
co-precipitation of two equivalents of ferric chloride and one 
equivalent of ferrous sulfate in sodium hydroxide solution 
protected by nitrogen gas under shaking.33 The precipitate 
was separated with a magnet and washed with deoxygen-
ated water. The SPIO nanoparticles were heated at 120°C 
for 12 hours, and then the products were collected by a 
magnet and washed with deoxygenated water for further 
usage. SPIO@SiO2 and SPIO@SiO2-NH2 nanoparticles were 
produced by the hydrolysis reaction on the surfaces of SPIO 
nanoparticles using TEOS or APTES,31 respectively.
For SPIO@dextran nanoparticle preparation, dextran with 
a molecular weight of 70 kDa was first dissolved in a sodium 
hydroxide solution and refluxed for 2 hours. This solution 
was then added drop-wise to the ultrasonically dispersed 
SPIO nanoparticles in water with the pH value adjusted to 
3. The mixture was stirred and refluxed for 30 minutes. The 
products were separated with a magnet and washed with 
deoxygenated water.
The morphology of synthesized SPIO nanoparticles were 
characterized under a transmission electron microscope (TEM) 
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(Philips CM-120; Philips, Amsterdam, The Netherlands), 
and the diameter for each kind of SPIO nanoparticle was 
measured. Fourier transform infrared (FT-IR) spectra of each 
synthesized SPIO nanoparticles were studied to confirm the 
presence of specific surface coating with wave   numbers in 
a range of 500–4000 cm−1 by a FT-IR spectrometer (Nicolet 
670, Madison, WI), using a potassium bromide wafer. 
A Beckman Coulter Delsa 440SX zeta-potential   analyzer 
was used to determine the zeta potential of the SPIO 
nanoparticles.   Measurements were performed in 10 mM 
Hepes buffer at pH 7.4.
SPIO nanoparticle stability in culture 
medium
To determine the dispersible property of each kind of nano-
particle under the culture medium Dulbecco’s Modified 
Eagle Medium (DMEM) (Invitrogen, Carlsbad, CA), each 
nanoparticle was added into the DMEM without serum, 
followed by incubation at 37°C for 1 hour. The SPIO nano-
particles with or without incubation in DMEM medium 
were added onto the carbon-coated copper grid. The sample 
grids were dried prior to TEM.
In vitro MRI relativity measurement
Magnetic resonance relaxometry of the nanoparticles was 
performed by using a clinical 1.5 T whole-body MRI system 
(Siemens Sonata, Erlangen, Germany) in combination with a 
knee radio frequency coil for excitation and signal reception. 
Four SPIO nanoparticle samples were dispersed in distilled 
H2O at iron concentrations in a range from 0.1 to 10.0 µg/mL. 
For magnetic resonance measurements, dispersed SPIO 
nanoparticle solutions (1.0 mL) at different concentrations 
were filled in each Eppendorf tube (1.5 mL). Sonication was 
applied for 10 minutes prior to MRI. T2 relaxation times were 
measured by using a standard Carr–Purcell–Meiboom–Gill 
pulse sequence (repetition time [TR] = 2000 milliseconds, 
echo time [TE] range = 30–960 ms, 32 echoes, field-of-
view [FOV] = 134 × 67 mm2, matrix = 128 × 64, slice thick-
ness = 5 mm, number of excitations = 3). T2 relaxation times 
were calculated by a linear fit of the logarithmic region off 
interest signal amplitudes versus TE. The T2 relaxivities (r2) 
were determined by a linear fit of the inverse relaxation times 
as a function of the iron concentrations used.
Cell culture
The breast cancer cells (MCF-7), MDA-MB-231 cells, colon 
cancer cells (HT-29), mouse macrophage cells (RAW 264.7), 
mouse fibroblast cells (L929), human hepatoma cells 
(HepG2), human prostate cancer cells (PC-3), and human 
glioblastoma cells (U-87 MG) were obtained from American 
Type Culture Collection (ATCC, Manassas, VA) and cultured 
with DMEM (Invitrogen) containing 10% fetal bovine serum 
(FBS), 100 U/mL penicillin, and 100 µg/mL streptomycin at 
37°C and in a humidified 5% CO2 atmosphere. The MSCs 
were primarily derived from mouse bone marrow under 
the following procedures.34 Under sterilized conditions, 
bone marrow was harvested with phosphate-buffered saline 
(PBS) from tibia and femoral medullary cavity flushes of 
4-week-old C57BL/6 mice (Jackson Labs, Bar Harbor, ME). 
Mononuclear cells were isolated by density gradient centrifu-
gation and cultured with α-MEM (alpha-modified minimum 
essential medium) containing 20% FBS, 100 U/mL penicillin, 
and 100 µg/mL streptomycin in the incubator. MSC colonies 
were further expanded; passage three MSCs were used for 
further experiments.
Cellular labeling of SPIO nanoparticles
About 5000–10,000 of each type of cell were seeded into 
each well of the 24-well plates. After 12 hours of incuba-
tion, the culture medium was replaced with the serum-free 
DMEM containing different types of SPIO nanoparticles 
with 4.5 µg/mL iron concentration. The cells were further 
incubated for 24 hours. Iron concentration of 4.5 µg/mL 
was used based on the results of a previous publication.29 
The pilot study confirmed iron concentration of 4.5 µg/mL 
did not affect the cell viability of any cell lines used in this 
study. The pilot study also observed that .10 µg Fe/mL of 
SPIO nanoparticles did not enhance cell uptake efficiency, 
whereas at very high concentrations, such as 50 µg Fe/mL, 
nanoparticles tended to aggregate in the culture medium and 
to adhere to the plastic plate bottom.
Prussian blue staining for SPIO 
nanoparticle-labeled cells
After incubation with SPIO nanoparticles, the cells were 
washed with PBS to remove any free SPIO nanoparticles. 
Cells were fixed for 40 minutes using 4% paraformaldehyde 
(Sigma-Aldrich). Then, cells were washed with PBS 
and incubated with fresh prepared Perls’ reagent (4% 
potassium ferrocyanide [Sigma-Aldrich]/12% HCl, 1:1, 
v/v) for 30 minutes. The cells were washed three times 
with PBS, counterstained with neutral red (0.02%) (Sigma-
Aldrich), and subsequently observed by an inverted optical 
microscope.35,36 For each cell line, the comparative labeling 
efficiency of each type of SPIO nanoparticle was assessed 
visually by two readers (XMZ, 7 years experience of 
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cell biology and 2 years experience of reading SPIO cell 
labeling; and YXJW, 3 years experience of cell biology 
and 3 years experience of reading SPIO cell labeling), 
and consensus was reached. The experiment was carried 
out three times. With Prussian blue staining assessment, 
MCF-7 cells, MDA-MB-231 cells, and HT-29 cells failed 
to show notable iron uptake, and were thereafter excluded 
from further studies.
Intracellular iron content measurement
Colorimetric method was used to study the iron concentra-
tion for SPIO nanoparticles or cell samples labeled by SPIO 
nanoparticles.37 For the intracellular iron content quantifica-
tion, after the cells were incubated with SPIO nanoparticles 
with 4.5 µg/mL iron concentration for 24 hours, the cells 
were washed, collected, and counted. After 4500 g cen-
trifugation for 5 minutes, the collected cell pellets were 
dispensed in 100 µL 12% HCl solution and incubated at 
60°C for 4 hours. After incubation, the suspension was 
centrifuged at 12,000 × g for 10 minutes, and the superna-
tants were collected for iron concentration quantification. 
A volume of 50 µL of sample solution was added into the 
wells of a 96-well plate, and then 50 µL of 1% ammo-
nium persulfate (Sigma-Aldrich) was added to oxidize 
the ferrous ions to ferric ions.38 Finally, 100 µL of 0.1 M 
potassium thiocyanate (Sigma-Aldrich) was added to the 
solution and incubated for 5 minutes to form the red color 
iron-thiocyanate. The absorption was read by a microplate 
reader (Model 3550; Bio-Rad, Richmond, CA) at a wave-
length of 490 nm.
In vitro MRI of mouse MSCs labeled  
with SPIO nanoparticles
In vitro MRI was performed with mouse MSCs labeled 
with the four types of SPIO nanoparticles (4.5 µg Fe/
mL) for 24 hours. After washing with PBS, the cells were 
trypsinized and counted. Different numbers (0, 1 × 103, 
3 × 103, 6 × 103, 1 × 104, 3 × 104, 6 × 104, 1 × 105, or 3 × 105) 
of cells were placed in an Eppendorf tube (1.5 mL). After 
centrifugation at 4000 rpm for 5 minutes, the Eppendorf 
tubes were placed perpendicular to the main magnetic 
induction field (B0) in a 20 cm × 12 cm × 8 cm water bath. 
MRI was performed with a 3.0-T clinical whole-body 
magnetic resonance unit (Achieva; Philips Medical Systems, 
Best, The Netherlands), using a transmit–receive head coil. 
The magnetic resonance sequence was a two-dimensional 
gradient-echo sequence with TR/TE = 400/48 milliseconds, 
flip angle = 18°, matrix = 512 × 256, resolution = 0.45 × 0.45 mm, 
slice thickness = 2 mm, and number of excitations = 2. 
Sagittal images were obtained through the central section of 
the bottom tips of the Eppendorf tubes. The areas of signal 
void at the bottom of the Eppendorf tubes due to SPIO 
nanoparticle-labeled cell pellets were compared visually by 
a radiologist (YXJW) with past experience.29,39
Biocompatibility assay
The cytotoxicity of each different type of SPIO nanoparticle 
was examined by methylthiazolyldiphenyl-tetrazolium bromide 
(MTT) assay40 in RAW 264.7 cells. A total of 10,000 RAW 
264.7 cells were seeded into the wells of a 96-well plate. After 
12 hours incubation, the medium in the wells was replaced 
with 100 µL serum-free DMEM containing different iron 
concentrations (0, 10, 20, 50, 100, or 200 µg/mL) of each SPIO 
nanoparticle. After 24 hours incubation, cells were washed 
with PBS once, and 100 µL fresh medium containing 0.5 mg/
mL MTT (Sigma-Aldrich, St Louis, MO) was added into 
each well. After 3 hours incubation, the medium was removed, 
and formazan crystals were dissolved with 150 µL dimethyl 
sulfoxide for 10 minutes on a shaker. A flat magnet was put 
under the plate to attract the magnetic particles to the bottom of 
the well. Then, 100 µL of supernatant was transferred to another 
96-well plate. The absorbance of each well was measured by a 
microplate reader (Model 3550, Bio-Rad, Richmond, CA) at a 
wavelength of 540 nm. The relative cell viability (%) for each 
sample related to control well was calculated.
Statistical analysis
Data were presented as mean ± standard deviation. Statistical 
difference was evaluated with Mann–Whitney test or one-
way analysis of variance. P values ,0.05 were considered 
statistically significant.
Results
Characterization of synthesized SPIO 
nanoparticles
Monodispersed SPIO@SiO2-NH2, SPIO@SiO2, bare SPIO, 
and SPIO@dextran nanoparticles were successfully synthe-
sized, as TEM images showed (Figure 1A). These four types 
of nanoparticles possessed a similar SPIO core size of 7 nm, 
and together with their coating, the overall sizes ranged from 
7 to 15 nm. FT-IR spectra for each type of SPIO nanopar-
ticle are shown in Figure 2. The typical absorbance band of 
Fe-O stretching vibration at 580 cm−1 could be found in all 
IR spectra. The broad peak that appeared in the region of 
3200–3600 cm−1 corresponds to the O-H stretching   vibration 
as the bare SPIO nanoparticle (Figure 2C) surfaces were 
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readily covered with hydroxyl groups.41 The IR spectra of 
SPIO@SiO2-NH2 (Figure 2A) and SPIO@SiO2 (Figure 2B) 
nanoparticles exhibited a broad absorption band centered at 
1050 cm−1, which were coming from the vibrations of the 
Si-O-Si network, and suggested that the SPIO nanoparticles 
were encapsulated by a layer of silica. The N-H stretching 
from the amino groups of APTES was suggested to give a 
broad peak at 3300–3500 cm−1;42 however, this signal was 
masked by the broad hydroxyl vibrations. Nevertheless, the 
presence of amine could be confirmed by a previous elec-
trodiagnostic study, which showed the presence of nitrogen 
element in SPIO@SiO2-NH2 nanoparticles.29 In addition, the 
IR spectrum of SPIO@dextran (Figure 2D) nanoparticles 
showed a complex absorption band with several maxima 
in the region between 1200 and 1000 cm−1, in which these 
bands are commonly found in most carbohydrate deriva-
tives including dextran, suggesting these SPIO nanoparticles 
were effectively coated with dextran. At pH 7.4, the zeta 
potentials were 11.8 ± 8.4, −35.8 ± 16.4, −38.5 ± 17.7 mV , 
and −6.9 ± 5.6 mV for SPIO@SiO2-NH2, SPIO@SiO2, bare 
SPIO, and SPIO@dextran nanoparticles, respectively. The in 
vitro stability assay in culture medium indicated that the bare 
SPIO nanoparticles aggregated after 1 hour DMEM incubation 
(Figure 1B). However, SiO2-NH2, SiO2, and dextran coatings 
prevented severe aggregation of nanoparticles, and these 
nanoparticles remained well dispersed (Figure 1B). The MRI 
relaxivities (r2) were 106.8 ± 15.1, 155.8 ± 14.6, 83.2 ± 16.0, 
and 101.4 ± 18.2 mM−1 s−1 for SPIO@SiO2-NH2, SPIO@SiO2, 
bare SPIO, and SPIO@dextran nanoparticles, respectively.
SPIO nanoparticle uptake evaluated  
with Prussian blue staining
The typical Prussian blue staining images of the six   different 
cells internalized with these four SPIO nanoparticles are 
shown in Figure 3. The visual assessment of each SPIO 
A
Before
SPIO@SiO2-NH2 SPIO@SiO2 SPIO@dextran Bare SPIO
After
incubation
incubation
B
Figure 1 Transmission electron microscopy images of synthesized SPIO@SiO2-NH2, SPIO@SiO2, bare SPIO, and SPIO@dextran (A) and after 1 hour incubation in 
Dulbecco’s modified Eagle’s medium (B).
Notes: Dark dots represent the core of a single SPIO nanoparticle measuring approximately 7 nm in diameter. The coating is observed as a thin and white layer around 
each single iron oxide core. Bare SPIO nanoparticles tended to aggregate together in the culture medium; however, SPIO@SiO2-NH2, SPIO@SiO2, and SPIO@dextran 
nanoparticles remained monodispersed.
Abbreviations: SPIO, superparamagnetic iron oxide; SPIO@SiO2-NH2, aminosilane-coated SPIO nanoparticles; SPIO@SiO2, SiO2-coated SPIO nanoparticles; SPIO@dextran, 
dextran-coated SPIO nanoparticles.
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Figure 2 Fourier transform infrared spectra of SPIO@SiO2-NH2 (A), SPIO@SiO2 
(B), bare SPIO (C), and SPIO@dextran (D) nanoparticles.
Notes: The broad absorption band at 1050 cm−1 originates from the vibrations of 
Si-O-Si network. The complex absorption band in the region of 1200–1000 cm−1 
indicates the dextran coating.
Abbreviations: SPIO, superparamagnetic iron oxide; SPIO@SiO2-NH2, aminosilane-
coated SPIO nanoparticles; SPIO@SiO2, SiO2-coated SPIO nanoparticles; SPIO@
dextran, dextran-coated SPIO nanoparticles.
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nanoparticle for the six cell lines is shown in Table 1. 
According to visual assessment (Figure 3 and Table 1), 
SPIO@SiO2-NH2 had a highest cellular uptake efficiency 
among the four SPIOs. For SPIO@SiO2, bare SPIO, and 
SPIO@dextran nanoparticles, there were variations of 
labeling efficiency among different cell lines, whereas 
SPIO@SiO2 tended to rank as the second, and SPIO@dextran 
tended to have lowest labeling efficiency.
Intracellular iron content
The intracellular iron content for the four types of SPIO 
nanoparticles in six cell lines is demonstrated in Figure 4. 
Comparing the iron uptake of four types of SPIO nano-
particles in the six different cell lines, each cell group 
treated with SPIO@SiO2-NH2 nanoparticles showed the 
highest iron content. For SPIO@SiO2, bare SPIO, and 
SPIO@dextran nanoparticles, there were variations of 
labeling efficiency among different cell lines, with SPIO@
SiO2 tending to rank second, and bare SPIO and SPIO@
dextran tending to have lower labeling efficiency. For the 
same SPIO nanoparticles, the intracellular iron content 
in different cell lines was variable. For SPIO@SiO2-NH2 
nanoparticles, the highest accumulation was observed in 
U-87 MG cells and MSCs.
SPIO@SiO2-NH2
L929
RAW 264.7
HepG2
PC-3
U-87 MG
MSCs
25 µm
SPIO@SiO2 Bare SPIO SPIO@dextran
Figure 3 Prussian blue staining of iron in six mammalian cell lines. L929, RAW 264.7, Hepg2, PC-3, U-87 Mg, and primary cultured mouse mesenchymal stem cells were 
incubated with SPIO nanoparticles at iron concentration of 4.5 µg/mL for 24 hours.
Notes: The morphology of these cells were not changed, and blue granules were evident at the cytoplasm around the nuclei. Scale bar = 25 µm.
Abbreviations: SPIO, superparamagnetic iron oxide; SPIO@SiO2-NH2, aminosilane-coated SPIO nanoparticles; SPIO@SiO2, SiO2-coated SPIO nanoparticles; SPIO@
dextran, dextran-coated SPIO nanoparticles.
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Table 1 Rank order of cellular uptake efficiency of four SPIO nanoparticles by visual assessment
Cell line SPIO@SiO2-NH2 SPIO@SiO2 Bare SPIO SPIO@dextran
L929 1 2a 2a 3
RAW 264.7 1 2 3a 3a
Hepg2 1 3a 2 3a
PC-3 1 2 3a 3a
U-87 Mg 1 2 4 3
MSCs 1 2 4 3
Note: asimilar cellular uptake efficiency.
Abbreviations: MSC, mesenchymal stem cell; SPIO, superparamagnetic iron oxide; SPIO@SiO2-NH2, aminosilane-coated SPIO nanoparticles; SPIO@SiO2, SiO2-coated 
SPIO nanoparticles; SPIO@dextran, dextran-coated SPIO nanoparticles.
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Figure 4 Intracellular iron content study in L929, RAW 264.7, Hepg2, PC-3, U-87 Mg, and primary cultured mouse MSCs after 24 hours incubation of SPIO nanoparticles 
with iron concentration at 4.5 µg/mL.
Note: Data were expressed as means ± standard deviations from three experiments.
Abbreviations: MSC, mesenchymal stem cell; SPIO, superparamagnetic iron oxide; SPIO@SiO2-NH2, aminosilane-coated SPIO nanoparticles; SPIO@SiO2, SiO2-coated 
SPIO nanoparticles; SPIO@dextran, dextran-coated SPIO nanoparticles.
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MRI of MSCs labeled with SPIO 
nanoparticles
MRI of MSCs labeled with SPIO nanoparticles is shown in 
Figure 5. For all four nanoparticles, substantial negative con-
trast (dark MRI signal) was observed with cell pellets of more 
than 30,000 cells leading to a “ballooning” effect. For the 
cell pellets of 10,000 cells, SPIO@SiO2-NH2 nanoparticle-
labeled cells had stronger MRI signals than that of SPIO@
SiO2 or SPIO@dextran nanoparticles, whereas bare SPIO 
nanoparticle-labeled cells were not detectable.
Cell viability
The results of RAW 264.7 cell viability post SPIO incubation 
is shown in Figure 6. The SPIO@SiO2-NH2, bare SPIO, and 
SPIO@dextran nanoparticles did not affect the cell viability 
of RAW 264.7 cells, even at highest iron concentration of 
200 µg/mL. However, SPIO@SiO2 nanoparticles negatively 
affected RAW 264.7 cell viability at iron concentrations from 
10 to 200 µg/mL in a dose-dependent manner.
Discussion
In the present study, monodispersed SPIO nanoparticles 
coated with aminosilane (SiO2-NH2), SiO2, or dextran, as 
well as bare SPIO nanoparticles, were synthesized. These 
four SPIO nanoparticles’ cellular uptake efficiencies 
were evaluated in a number of mammalian cell lines, 
and their cytotoxicities were assessed with macrophage 
RAW 264.7 cells. The T2 relaxivities (r2) of these four 
SPIO nanoparticles are in the range of previously reported 
SPIO, and compared favorably with known SPIOs of 
similar sizes. The r2 values of VSOP-C184 (diameter 
7 nm, Ferropharm, Teltow, Germany), SHU-555C 
(diameter 21 nm, Schering, Berlin, Germany), and Sinerem 
(diameter 15–30 nm, Guerbet, France) are 33.4 mM−1s−1, 
38 mM−1s−1, and 65 mM−1s−1, respectively.6,7 For a passive 
targeting mechanism such as enhanced permeability and 
retention effect to work, the size of nanoparticles must 
be controlled to avoid uptake by the reticuloendothelial 
system. The nanoparticle size range of 7–15 nm would be 
suitable from this aspect as well as maintaining sufficient 
magnetic properties.43 SPIO nanoparticles can aggregate 
under culture medium with high ionic strength. In this study, 
TEM results indicated that the bare SPIO nanoparticles 
tended to aggregate in culture medium, while aminosilane 
or silica coating as well as dextran coating prevented the 
nanoparticle aggregation.
SPIO@SiO2-NH2
SPIO@SiO2
SPIO@dextran
6,000 10,000 30,000
Cell number
60,000 100,000 300,000
Bare SPIO
Figure 5 gradient echo MRI images of mouse mesenchymal stem cell pellets labeled with SPIO nanoparticles (4.5 µg Fe/mL) in Eppendorf tubes with culture medium.
Notes: The cell number in each Eppendorf tube was 0, 1 × 103, 3 × 103, 6 × 103, 1 × 104, 3 × 104, 6 × 104, 1 × 105, or 3 × 105. For all cell pellets, SPIO@SiO2-NH2 nanoparticle-
labeled cells had strongest MRI signal void. For the cell pellets of 10,000 cells, bare SPIO nanoparticle-labeled cells were not detectable.
Abbreviations: MRI, magnetic resonance imaging; SPIO, superparamagnetic iron oxide; SPIO@SiO2-NH2, aminosilane-coated SPIO nanoparticles; SPIO@SiO2, SiO2-coated 
SPIO nanoparticles; SPIO@dextran, dextran-coated SPIO nanoparticles.
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Cancerous cell lines MCF-7, MDA-MB-231, HT-29, 
HepG2, PC-3, and U-87 MG are representative cell lines for 
studying cancer cell biology. In this study, MSCs were also 
selected due to the potential application of SPIO nanoparticle 
labeling for in vivo MRI monitoring. The mouse macrophage 
cells (RAW 264.7) were selected in this study, as these cells 
have macrophagic functions, and after in vivo administration 
of SPIO nanoparticles, these particles may be ultimately 
cleared from the tissues by the host macrophage. The uptake 
of SPIO by phagocytic monocytes and macrophages may 
provide a valuable in vivo tool by which MRI can be used 
to monitor the involvement of macrophages in inflamma-
tory processes.8,44–47 As demonstrated in this study, cellular 
uptake efficiency of SPIO nanoparticles was dependent on 
the characteristics of cell lines themselves as well as the 
surface coating of nanoparticles. Among these two factors, 
the biological nature of cell lines may have the prior impor-
tance. MCF-7, MDA-MB-231, and HT-29 cells had poor 
nanoparticle uptake efficiencies for all four types of SPIO 
nanoparticles. On the other hand, L929, RAW 264.7, HepG2, 
PC-3, U-87 MG cells, and mouse bone marrow-derived 
MSCs displayed substantial nanoparticle cellular uptake 
capabilities. In the current study, with both Prussian blue 
staining and intracellular iron content quantification, it was 
observed that all these six mammalian cell lines showed the 
highest cellular uptake for SPIO@SiO2-NH2 nanoparticles. 
Moreover, the intracellular iron content in U-87 MG and 
mouse MSCs were nearly four times that of any other type 
of cells. This result may be partly because both U-87 MG 
and MSCs have bigger cell sizes than the other cell lines 
(Figures 3 and 4). The authors of this present paper have 
previously reported that surface amine modification enhances 
labeling efficiency for rabbit MSCs of SPIO@SiO2-
NH2 nanoparticles fourfold compared with SPIO@SiO2 
  nanoparticles.29 That finding was in agreement with the 
current result of mouse MSCs (Figure 4F). In another study, 
the high cellular labeling efficiency of SPIO@SiO2-NH2 
nanoparticles was also seen in human osteosarcoma line 
U2OS.39 The mouse MSC pellets MRI study confirmed the 
higher uptake with SPIO@SiO2-NH2 nanoparticles can be 
translated to higher MRI contrast readout (Figure 5).
Surface charge can be important for intracellular delivery 
of exogenous material. It has been shown that ionic SPIO 
performed better than nonionic SPIO for cell labeling.48 
The difference in surface charges between these nanopar-
ticles might provide insights on how the coatings of SPIO 
affect the cell labeling efficacy. Under pH value less than 8, 
the protonation of amino groups on aminosilane-modified 
magnetic nanoparticles occur, resulting in surface positive 
charges.49 Due to the hydroxyl group present on the surface 
of SPIO@SiO2 and bare nanoparticles, these two nanopar-
ticles are negatively charged.21 In the present study, the zeta 
potential measurement illustrated that under pH 7.4, only 
SPIO@SiO2-NH2 nanoparticles were positively charged. It is 
also known that plasma membranes possess large negatively 
charged domains, which should repel anionic nanoparticles, 
but cationic surfaces have been shown to facilitate cellular 
internalization.50 This may partially explain why SPIO@SiO2-
NH2 nanoparticles have higher cellular labeling efficiency than 
SPIO@SiO2 nanoparticles. The question of whether SiO2-NH2 
coating will enhance nanomaterial’s uptake efficiency other 
than SPIO will be interesting and warrant further study.
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Figure 6 Cell viability of RAW 264.7 cells as determined by MTT assay after incubation with each type of SPIO nanoparticles at different iron concentrations for 24 hours.
Notes: Data are expressed as means ± standard deviations from six experiments; #P , 0.001.
Abbreviations: MTT, methylthiazolyldiphenyl-tetrazolium bromide; SPIO, superparamagnetic iron oxide; SPIO@SiO2-NH2, aminosilane-coated SPIO nanoparticles; SPIO@
SiO2, SiO2-coated SPIO nanoparticles; SPIO@dextran, dextran-coated SPIO nanoparticles.
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Compared with SPIO@SiO2-NH2 or SPIO@SiO2 
nanoparticles, noncoated and dextran-coated SPIO 
nanoparticles were found to be less uptaken in all six 
cell lines. The results showed in DMEM culture medium 
the colloidal stability of uncoated SPIO nanoparticles is 
difficult to achieve, which might be one of the reasons for 
its low cellular uptake efficiency. In agreement with the 
present results, Kunzmann et al reported that silica-coated 
SPIO nanoparticles were taken up to a greater extent when 
compared with dextran-coated particles in primary human 
macrophages.51 The dextran-coated iron oxide nanoparticles 
do not present sufficient cellular uptake to enable cell 
tracking, which is probably due to a relatively inefficient 
fluid-phase endocytosis pathway.52–54 During in vitro cellular 
labeling procedures, some authors use transfection agents 
to increase the SPIO cell labeling efficiency.55 Transfection 
agents are highly charged macromolecules that have been 
used to transfect oligonucleotides into cells via electrostatic 
interaction, which results in endosome formation. By 
themselves, transfection agents are toxic to cells, and the toxic 
effect is proportional to the transfection agent concentration.56 
It is advantageous that a high intracellular labeling efficiency 
can be achieved with SPIO@SiO2-NH2 nanoparticles without 
the use of any transfection agent.
The results from this study may suggest that cancers with 
biological features similar to breast cancer MCF-7, MDA-
MB-231 cells, and colon cancer HT-29 cells may be less 
amenable to certain types of targeted therapy, while cancers 
with biological features similar to cancerous cells HepG2, 
PC-3, and U-87 MG may be more responsive to these types 
of targeted therapy. This study shows that the U-87 MG 
glioblastoma cell line had SPIO@SiO2-NH2 nanoparticle 
accumulation four times higher than other cell lines. It 
is possible that human glioblastoma may be particularly 
suited for SPIO@SiO2-NH2-mediated cellular imaging or 
targeted therapy.
Surface coating can influence nanoparticle cellular uptake 
behavior as well as their cytotoxicities. In this study, by 
way of example, the dependence of cytotoxicity on surface 
coating of SPIO nanoparticles was investigated by using the 
mouse macrophage RAW 264.7 cells. The results showed the 
SPIO@SiO2-NH2, bare SPIO, and SPIO@dextran nanopar-
ticles did not affect the cell viability of RAW 264.7 cells, even 
at an iron concentration of 200 µg/mL. However, SPIO@
SiO2 nanoparticles negatively affected RAW 264.7 cell 
viability at iron concentrations between 10 and 200 µg/mL 
in a dose-dependent manner. Gozal et al reported that RAW 
264.7 cells are sensitive to silica, and exhibited enhanced 
tumor necrosis factor-α production and nuclear factor-κB 
activation, which lead to cell apoptosis.57 This result is also 
consistent with the finding reported by Kunzmann et al that 
smaller silica-coated SPIO nanoparticles (30 and 50 nm) 
rather than dextran-coated nanoparticles displayed dose-
dependent cytotoxic effect.51 The aminosilane improves the 
biocompatibility of silica coating which may be partly due to 
the organic modification of the silica coating and limits the 
interaction between silica and intracellular organelles.
Conclusion
This study demonstrated aminosilane-coated SPIO nano-
particles possessed a higher in vitro cell labeling efficiency 
compared with silica, bare, and dextran-coated SPIO nanopar-
ticles across a number of mammalian cell lines.   Aminosilane 
also improved the biocompatibility of silica coating. 
  Aminosilane-coated SPIO nanoparticles may have promising 
potential for cellular imaging, drug-targeted   delivery, and 
magnetic separation for blood and serum samples.
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